Abstract
Therapeutic application of the recently discovered small interfering RNA (siRNA) gene silencing phenomenon will be dependent on improvements in molecule bio-stability, specificity and delivery. To address these issues, we have systematically modified siRNA with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA). Here, we show that incorporation of LNA substantially enhances serum half-life of siRNA's, which is a key requirement for therapeutic use. Moreover, we provide evidence that LNA is compatible with the intracellular siRNA machinery and can be used to reduce undesired, sequence-related off-target effects. LNA-modified siRNAs targeting the emerging disease SARS, show improved efficiency over unmodified siRNA on certain RNA motifs. The results from this study emphasize LNA's promise in converting siRNA from a functional genomics technology to a therapeutic platform.
MeSH Terms
Animals
Cell Line
Chlorocebus aethiops
Humans
Oligonucleotides
Oligonucleotides, Antisense/chemistry
PC12 Cells
RNA Interference
RNA Stability
RNA, Small Interfering/blood,chemistry,pharmacology
Rats
Vero Cells
Chemicals
Oligonucleotides
Oligonucleotides, Antisense
RNA, Small Interfering
locked nucleic acid
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Elmén Joacim
Center for Genomics and Bioinformatics, Karolinska Institutet 171 77 Stockholm, Sweden.
[email protected]
Thonberg Håkan
Ljungberg Karl
Frieden Miriam
Westergaard Majken
Xu Yunhe
Wahren Britta
Liang Zicai
Ørum Henrik
Koch Troels
Wahlestedt Claes
References (27)
27 references, click to expand
-
A species of small antisense RNA in posttranscriptional gene silencing in plants.
Science. 1999 Oct 29;286(5441):950-2
PMID: 10542148
-
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
Nature. 1998 Feb 19;391(6669):806-11
PMID: 9486653
-
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5633-8
PMID: 10805816
-
The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models.
J Neurosci Methods. 2000 May 15;98(1):9-20
PMID: 10837866
-
Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity.
Chemistry. 2000 Aug 4;6(15):2687-95
PMID: 10985717
-
RNA interference is mediated by 21- and 22-nucleotide RNAs.
Genes Dev. 2001 Jan 15;15(2):188-200
PMID: 11157775
-
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA.
Chem Biol. 2001 Jan;8(1):1-7
PMID: 11182314
-
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
Nature. 2001 May 24;411(6836):494-8
PMID: 11373684
-
ATP requirements and small interfering RNA structure in the RNA interference pathway.
Cell. 2001 Nov 2;107(3):309-21
PMID: 11701122
-
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.
EMBO J. 2001 Dec 3;20(23):6877-88
PMID: 11726523
-
Design of antisense oligonucleotides stabilized by locked nucleic acids.
Nucleic Acids Res. 2002 May 1;30(9):1911-8
PMID: 11972327
-
Design and characterization of decoy oligonucleotides containing locked nucleic acids.
Nucleic Acids Res. 2002 Jun 1;30(11):2435-43
PMID: 12034831
-
RNAi in human cells: basic structural and functional features of small interfering RNA.
Mol Cell. 2002 Sep;10(3):549-61
PMID: 12408823
-
Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
Nucleic Acids Res. 2002 Dec 1;30(23):5160-7
PMID: 12466540
-
Tolerance for mutations and chemical modifications in a siRNA.
Nucleic Acids Res. 2003 Jan 15;31(2):589-95
PMID: 12527766
-
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
Nucleic Acids Res. 2003 Jun 1;31(11):2705-16
PMID: 12771196
-
Expression profiling reveals off-target gene regulation by RNAi.
Nat Biotechnol. 2003 Jun;21(6):635-7
PMID: 12754523
-
Killing the messenger: short RNAs that silence gene expression.
Nat Rev Mol Cell Biol. 2003 Jun;4(6):457-67
PMID: 12778125
-
Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Antisense Nucleic Acid Drug Dev. 2003 Apr;13(2):83-105
PMID: 12804036
-
Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs.
Biochem Biophys Res Commun. 2003 Jul 4;306(3):712-7
PMID: 12810077
-
RNA interference in mammalian cells by chemically-modified RNA.
Biochemistry. 2003 Jul 8;42(26):7967-75
PMID: 12834349
-
Asymmetry in the assembly of the RNAi enzyme complex.
Cell. 2003 Oct 17;115(2):199-208
PMID: 14567917
-
Functional siRNAs and miRNAs exhibit strand bias.
Cell. 2003 Oct 17;115(2):209-16
PMID: 14567918
-
Rational siRNA design for RNA interference.
Nat Biotechnol. 2004 Mar;22(3):326-30
PMID: 14758366
-
siRNAs: applications in functional genomics and potential as therapeutics.
Nat Rev Drug Discov. 2004 Apr;3(4):318-29
PMID: 15060527
-
Characterization of RNA interference in rat PC12 cells: requirement of GERp95.
Biochem Biophys Res Commun. 2004 Jun 11;318(4):927-34
PMID: 15147961
-
RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.
Cell. 2000 Mar 31;101(1):25-33
PMID: 10778853